460 related articles for article (PubMed ID: 24556822)
1. Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases.
Sagi L; Zvulunov A; Lapidoth M; Ben Amitai D
Dermatology; 2014; 228(2):136-44. PubMed ID: 24556822
[TBL] [Abstract][Full Text] [Related]
2. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
[TBL] [Abstract][Full Text] [Related]
3. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
J Cutan Med Surg; 2012; 16(5):317-23. PubMed ID: 22971306
[TBL] [Abstract][Full Text] [Related]
4. The use of propranolol for complicated infantile hemangiomas.
Vercellino N; Romanini MV; Pelegrini M; Rimini A; Occella C; Dalmonte P
Int J Dermatol; 2013 Sep; 52(9):1140-6. PubMed ID: 23829783
[TBL] [Abstract][Full Text] [Related]
5. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study.
Zvulunov A; McCuaig C; Frieden IJ; Mancini AJ; Puttgen KB; Dohil M; Fischer G; Powell J; Cohen B; Ben Amitai D
Pediatr Dermatol; 2011; 28(2):94-8. PubMed ID: 21362031
[TBL] [Abstract][Full Text] [Related]
6. Propranolol treatment in life-threatening airway hemangiomas: a case series and review of literature.
Broeks IJ; Hermans DJ; Dassel AC; van der Vleuten CJ; van Beynum IM
Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1791-800. PubMed ID: 24074695
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of propranolol in the treatment of infantile hemangioma beyond the proliferation phase.
Vivas-Colmenares GV; Bernabeu-Wittel J; Alonso-Arroyo V; Matute de Cardenas JA; Fernandez-Pineda I
Pediatr Dermatol; 2015; 32(3):348-52. PubMed ID: 25721095
[TBL] [Abstract][Full Text] [Related]
8. Oral Propranolol for the Treatment of Infantile Hemangiomas in the Post-Proliferative Phase: A-Single Center Retrospective Study of 31 Cases.
Tian Y; Xu DP; Tong S; Xi SL; Liu ZM; Wang XK
J Oral Maxillofac Surg; 2016 Aug; 74(8):1623-9. PubMed ID: 27055227
[TBL] [Abstract][Full Text] [Related]
9. Retrospective study of the treatment of infantile hemangiomas using a combination of propranolol and pulsed dye laser.
Reddy KK; Blei F; Brauer JA; Waner M; Anolik R; Bernstein L; Brightman L; Hale E; Karen J; Weiss E; Geronemus RG
Dermatol Surg; 2013 Jun; 39(6):923-33. PubMed ID: 23458381
[TBL] [Abstract][Full Text] [Related]
10. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center.
Buckmiller LM; Munson PD; Dyamenahalli U; Dai Y; Richter GT
Laryngoscope; 2010 Apr; 120(4):676-81. PubMed ID: 20112413
[TBL] [Abstract][Full Text] [Related]
11. [Infantile hemangiomas: the revolution of beta-blockers].
Leaute-Labreze C
Rev Prat; 2014 Dec; 64(10):1421-8. PubMed ID: 25665327
[TBL] [Abstract][Full Text] [Related]
12. Late rebound of infantile hemangioma after cessation of oral propranolol.
Shehata N; Powell J; Dubois J; Hatami A; Rousseau E; Ondrejchak S; McCuaig C
Pediatr Dermatol; 2013; 30(5):587-91. PubMed ID: 24016283
[TBL] [Abstract][Full Text] [Related]
13. Propranolol treatment for infantile hemangioma: a case series of sixty-two patients.
Stringari G; Barbato G; Zanzucchi M; Marchesi M; Cerasoli G; Tchana B; Gritti A; Boccaletti V; Lombardi AA; Carano N
Pediatr Med Chir; 2016 Jun; 38(2):113. PubMed ID: 27345601
[TBL] [Abstract][Full Text] [Related]
14. [Infantile hemangioma and propranolol: a therapeutic "revolution". Literature review].
Yilmaz L; Dangoisse C; Semaille P
Rev Med Brux; 2013; 34(6):479-84. PubMed ID: 24505868
[TBL] [Abstract][Full Text] [Related]
15. Propranolol for infantile haemangioma: striking effect in the first weeks.
Katona G; Csákányi Z; Gács E; Szalai Z; Ráth G; Gerlinger I
Int J Pediatr Otorhinolaryngol; 2012 Dec; 76(12):1746-50. PubMed ID: 22944359
[TBL] [Abstract][Full Text] [Related]
16. Clinical and radiological outcomes of infantile hemangioma treated with oral propranolol: A long-term follow-up study.
Yu Z; Cai R; Chang L; Qiu Y; Chen X; Chen Q; Ma G; Jin Y; Lin X
J Dermatol; 2019 May; 46(5):376-382. PubMed ID: 30916822
[TBL] [Abstract][Full Text] [Related]
17. A further experience of propranolol for severe infantile hemangiomas of the face: an observational study.
Greco A; D'Erme AM; Zamma Gallarati B; Caputo R; de Martino M
Dermatol Ther; 2014; 27(4):198-202. PubMed ID: 24548454
[TBL] [Abstract][Full Text] [Related]
18. Safety and effectiveness of oral propranolol for infantile hemangiomas started before 5 weeks and after 5 months of age: an Italian multicenter experience.
El Hachem M; Gesualdo F; Diociaiuti A; Berti I; Vercellino N; Boccaletti V; Neri I; Porcedda G; Greco A; Carnevale C; Oranges T; Cutrone M; Dalmonte P
Ital J Pediatr; 2017 Apr; 43(1):40. PubMed ID: 28424095
[TBL] [Abstract][Full Text] [Related]
19. Outpatient treatment of infantile hemangiomas with propranolol: a prospective study.
Betlloch-Mas I; Martínez-Miravete MT; Lucas-Costa A; Martin de Lara AI; Selva-Otalaurruchi J
Actas Dermosifiliogr; 2012 Nov; 103(9):806-15. PubMed ID: 22727954
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with the relapse of infantile haemangiomas in children treated with oral propranolol.
Ahogo CK; Ezzedine K; Prey S; Colona V; Diallo A; Boralevi F; Taïeb A; Léauté-Labrèze C
Br J Dermatol; 2013 Dec; 169(6):1252-6. PubMed ID: 23662995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
